NET REVENUE

COST OF SALES
GROSS PROFIT
EBIT - OPERATING RESULT
EBITDA
NET INCOME
 Y3 % REV. Evolution % Diagnostic Y4 % REV. Evolution %
50,521.00 100.00% unknown unknown 53,417.00 100.00% 5.73%
33,194.00 65.70% unknown unknown 34,941.00 65.41% 5.26%
17,327.00 32.44% unknown unknown 18,476.00 34.59% 6.63%
14,613.00 27.36% unknown unknown 15,279.00 28.60% 4.56%
16,136.00 30.21% unknown unknown 16,741.00 31.34% 3.75%
1,959.00 3.67% unknown unknown 2,286.00 4.28% 16.69%
Diagnostic Y5 % REV. Evolution % Diagnostic
56,223.00 100.00% 5.25%
36,665.00 65.21% 4.93%
19,558.00 34.79% 5.86%
15,798.00 28.10% 3.40%
17,283.00 30.74% 3.24%
2,698.00 4.80% 18.02%
Case 1 ROE 10%
NI 200,000.00
Total Asseet Turnover 5
Net Sales 1,000,000.00

Amount of Average Stockholder's Equity 2,000,000.00

Case 2 NI 1,500,000.00
Net Sales 8,000,000.00
Average Stockholder's Equity 12,000,000.00
ROE 22%
Total Asseet Turnover 8.00

ROA 1.50
Amount of Average Total assets 1,000,000.00

Amount of Average Total assets

Case 3 ROE 15%

Net Profit Margin 10%
Total Asseet Turnover 5.00
Average Total assets 1,000,000.00

ROA 0.50
Amount of Average Stockholder's Equity 3,333,333.33

Case 4 NI 500,000.00
ROE 15%
Total Asseet Turnover 5
Net Sales 1,000,000.00
Financial Leverage 2

Amount of Average Total assets 200,000.00

 X

P/E 11
Gross Profit Margin 28.60
Profit Margin 2.8
Current Ratio 2

Cash coverage Ratio 0.7

debt-to-Equity 1.4

Return on Equity 12
Return on Assets 5.2
Dividend Yield Not Applicable
Earnings per share 5,17$
 Y
A bit riskier but Market is willing to
12.9 pay more for this company.
39.3
5.7
1.4
Good ability to service the debt on
2.2 its profit
More liabilities than equity. Greater
2 leverage than X
Better level of income attributed to
27.8 SH
9.3 Uses more efficiently its Assets
1.4 Dividend Paying performance
5,20$
 Y1 % REV.
NET REVENUE - 100.00%
COST OF SALES
GROSS PROFIT 0.00%
EBIT - OPERATING RESULT 0.00%
EBITDA 0.00%
NET INCOME 0.00%
Evolution % Diagnostic Y2 % REV. Evolution % Diagnostic Y3
#REF! - 100.00% #REF! ###
###
#REF! 0.00% #REF! ###
#REF! 0.00% #REF! ###
#REF! 0.00% #REF! ###
#REF! 0.00% #REF! ###
 % REV. Evolution % Diagnostic Y4 % REV. Evolution % Diagnostic
100.00% unknown unknown ### 100.00% 5.73%
65.70% unknown unknown ### 65.41% 5.26%
32.44% unknown unknown ### 34.59% 6.63%
27.36% unknown unknown ### 28.60% 4.56%
30.21% unknown unknown ### 31.34% 3.75%
3.67% unknown unknown ### 4.28% 16.69%
 Y5 % REV. Evolution % Diagnostic
### 100.00% 5.25%
### 65.21% 4.93%
### 34.79% 5.86%
### 28.10% 3.40%
### 30.74% 3.24%
### 4.80% 18.02%
 BLUE WATER % REV. PRIME FISH % REV.
NET REVENUE 447,000.00 100.00% 802,000.00 100.00%
COGS 241,000.00 53.91% 400,000.00 49.88%
GROSS PROFIT 206,000.00 46.09% 402,000.00 50.12%
OPEX 161,000.00 36.02% 311,000.00 38.78%
NET INCOME 45,000.00 10.07% 91,000.00 11.35%
0.00% 0.00%
0.00% 0.00%

OPERATING RATIOS
GROS PROFIT OVER SALES 36.02% 38.78%
OPEX / R Ratio 36.02% 38.78%
Evolution % Diagnostic
79.42%
65.98%
95.15%
93.17%
102.22%
#DIV/0!
#DIV/0!